Data on ARBs continue to impress. Stay informed on the implications of late-breaking trial data from the 2008 ESC meeting with interviews conducted by Dr Weber with Drs Pfeffer, McMurray, Swedberg, and Agabati-Rosei.
Join Drs Weber and Izzo as they take a hard look at stage I hypertensive patients and answer the question: Is lower better?
Acknowledgements
CME provider: The American Society of Hypertension, Inc.
Management strategies clinical theme is supported by an independent educational grant from Forest Pharmaceuticals, Inc., and Daiichi-Sankyo.